Geode Capital Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$79.8M Buy
1,444,230
+20,671
+1% +$1.14M 0.01% 1156
2025
Q1
$68.9M Buy
1,423,559
+46,496
+3% +$2.25M 0.01% 1187
2024
Q4
$53.2M Buy
1,377,063
+2,366
+0.2% +$91.3K ﹤0.01% 1391
2024
Q3
$61.9M Buy
1,374,697
+3,528
+0.3% +$159K 0.01% 1295
2024
Q2
$47.5M Buy
1,371,169
+77,430
+6% +$2.68M ﹤0.01% 1390
2024
Q1
$37.4M Buy
1,293,739
+45,455
+4% +$1.32M ﹤0.01% 1552
2023
Q4
$28.6M Buy
1,248,284
+67,028
+6% +$1.54M ﹤0.01% 1699
2023
Q3
$19.7M Buy
1,181,256
+104,072
+10% +$1.74M ﹤0.01% 1834
2023
Q2
$29.8M Buy
1,077,184
+151,191
+16% +$4.18M ﹤0.01% 1593
2023
Q1
$21.3M Buy
925,993
+46,102
+5% +$1.06M ﹤0.01% 1758
2022
Q4
$9.6M Buy
879,891
+52,435
+6% +$572K ﹤0.01% 2290
2022
Q3
$6.98M Buy
827,456
+5,535
+0.7% +$46.7K ﹤0.01% 2480
2022
Q2
$6.5M Sell
821,921
-11,000
-1% -$87K ﹤0.01% 2550
2022
Q1
$19.7M Buy
832,921
+54,840
+7% +$1.3M ﹤0.01% 1916
2021
Q4
$26.6M Buy
778,081
+49,151
+7% +$1.68M ﹤0.01% 1763
2021
Q3
$12.9M Buy
728,930
+15,092
+2% +$267K ﹤0.01% 2276
2021
Q2
$32M Buy
713,838
+68,159
+11% +$3.06M ﹤0.01% 1664
2021
Q1
$16.7M Buy
645,679
+137,378
+27% +$3.56M ﹤0.01% 1990
2020
Q4
$10.2M Buy
508,301
+69,187
+16% +$1.39M ﹤0.01% 2167
2020
Q3
$8.58M Buy
439,114
+70,744
+19% +$1.38M ﹤0.01% 2044
2020
Q2
$6.51M Buy
368,370
+74,774
+25% +$1.32M ﹤0.01% 2185
2020
Q1
$2.07M Buy
293,596
+22,998
+8% +$162K ﹤0.01% 2652
2019
Q4
$1.91M Buy
270,598
+9,425
+4% +$66.4K ﹤0.01% 3028
2019
Q3
$3.14M Buy
261,173
+57,322
+28% +$688K ﹤0.01% 2662
2019
Q2
$2.47M Buy
203,851
+71,207
+54% +$862K ﹤0.01% 2813
2019
Q1
$1.67M Buy
132,644
+14,947
+13% +$188K ﹤0.01% 2958
2018
Q4
$792K Sell
117,697
-128
-0.1% -$861 ﹤0.01% 3201
2018
Q3
$1.21M Sell
117,825
-8,202
-7% -$84.4K ﹤0.01% 3137
2018
Q2
$846K Sell
126,027
-15,657
-11% -$105K ﹤0.01% 3251
2018
Q1
$1.22M Buy
141,684
+1,707
+1% +$14.7K ﹤0.01% 3033
2017
Q4
$2.91M Buy
139,977
+27,135
+24% +$564K ﹤0.01% 2539
2017
Q3
$1.99M Buy
112,842
+5,962
+6% +$105K ﹤0.01% 2753
2017
Q2
$1.21M Buy
106,880
+5,662
+6% +$64K ﹤0.01% 3021
2017
Q1
$1.3M Buy
101,218
+1,850
+2% +$23.7K ﹤0.01% 2892
2016
Q4
$2.19M Buy
99,368
+6,548
+7% +$144K ﹤0.01% 2585
2016
Q3
$1.96M Buy
+92,820
New +$1.96M ﹤0.01% 2574